Skip to content
HT
Company

Updated:

Harpoon Therapeutics, Inc.

Harpoon Therapeutics, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001708493, and its reported...

Overview

Harpoon Therapeutics, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001708493, and its reported industry is Biological Products, (No Diagnostic Substances). In 10-K filed on 2023-03-27, it reported annual revenue of USD 31,915,000; net income of USD -67,731,000; total assets of USD 73,729,000 for the fiscal period ended 2022-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

Company overview

Legal name
Harpoon Therapeutics, Inc.
Classification
Company
Industry (SIC)
2836 — Biological Products, (No Diagnostic Substances)
Headquarters
South San Francisco, CA, United States
Incorporated in
DE
Fiscal year end
December 31
SEC CIK
0001708493

Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

Fiscal yearPeriod endRevenueNet incomeTotal assetsCash and equivalentsOperating cash flow
FY2022USD$31.9M-$67.7M$73.7M$51.6M-$89.2M
FY2021USD$23.7M-$116.7M$155.5M$44.7M-$122.2M
FY2020USD$17.4M-$49.9M$171.6M$21.2M-$8.6M
FY2019USD$5.8M-$55.6M$176.6M$88.7M-$2.9M

Recent SEC filings

FormFiledPeriodFiling
SC 13G—Form SC 13G
8-K8-K
8-K8-K
8-K8-K
SC 13D—Form SC 13D
8-K8-K
SC 13G—SCHEDULE 13G
8-K8-K
8-K8-K
SC 13D—SC 13D
8-K8-K
8-K8-K

Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.

Research Harpoon Therapeutics, Inc. in Altss

Track this company’s investors, transactions and relationships in Altss.

Book a demo

More Company profiles

Harpoon Therapeutics, Inc. | Company | Altss